British American Tobacco (BATS) Gets a Sell from RBC Capital
In a report released today, James Edwardes Jones from RBC Capital maintained a Sell rating on British American Tobacco, with a price target of £36.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Edwardes Jones covers the Consumer Defensive sector, focusing on stocks such as British American Tobacco, Heineken NV, and Diageo. According to TipRanks, Edwardes Jones has an average return of 4.0% and a 64.80% success rate on recommended stocks.
In addition to RBC Capital, British American Tobacco also received a Sell from Morgan Stanley’s Rashad Kawan in a report issued on February 12. However, yesterday, Barclays maintained a Buy rating on British American Tobacco (LSE: BATS).
Based on British American Tobacco’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p13.54 billion and a net profit of p3.25 billion. In comparison, last year the company earned a revenue of p13.53 billion and had a GAAP net loss of p1.45 billion
Based on the recent corporate insider activity of 99 insiders, corporate insider sentiment is neutral on the stock.
Read More on GB:BATS:
Disclaimer & DisclosureReport an Issue
- British American Tobacco Cancels Newly Repurchased Shares Under Buyback Programme
- British American Tobacco Cancels New Tranche of Repurchased Shares
- Organigram announces C$65.2M BAT private placement investment
- BAT Reaffirms 2026 Outlook as It Leans Further Into Smokeless Products
- British American Tobacco Cancels 111,000 Shares After Latest Buyback
